Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 34 filings·Updated 29 Sept 2026
Showing 10 of 34 filings.
29 Sept 20264 filings
Company UpdateChange in Directorate

Natraj Proteins Re-appoints Sharad Kumar Jain as Whole Time Director for 3-year term from Oct 1, 2026

Re-appointment of Whole Time Director

  • Re-appointment of Shri Sharad Kumar Jain as Whole Time Director and Executive Director.
  • Effective from 1 October 2026 for a 3-year term.
  • Approved by members at the 35th AGM on 29 September 2026.
  • Profile: BSc; 39 years in soya industry and real estate; core promoter.
  • Relationship with other directors: Nil.
  • Not debarred by SEBI or authorities.
Filed 20:55View Source
AGM/EGMAGM

Natraj Proteins Ltd 35th AGM via VC/OAVM: all resolutions approved, WTD reappointed

AGM Details

  • Date/time/mode: 29 September 2026, 2:00 PM, via VC/OAVM.
  • Venue deemed at registered office, Itarsi; meeting concluded at 2:20 PM.

Resolutions and outcomes

  • Adoption of audited financial statements and reports: Passed with requisite majority.
  • Re-appointment of Shri Kailash Chand Sharma, retiring by rotation: Passed with requisite majority.
  • Ratification of remuneration to Yogesh Chourasia & Associates for 2026-27: Passed with requisite majority.
  • Re-appointment of Shri Sharad Kumar Jain as Whole Time Director from 1 Oct 2026: Passed with requisite majority.

Dividend

  • No dividend proposed or declared.
Filed 20:40View Source
AGM/EGMAGM

Natraj Proteins Limited: 35th AGM results — all resolutions passed including director rotations and WTD appointment

AGM Details

  • Date, time, mode: 29 September 2026, 2:00 PM–2:20 PM, VC/OAVM.
  • Venue: deemed at registered office, Nagpur-Kalan, Itarsi (M.P.).

Key Resolutions & Outcomes

  • Ordinary: Adoption of audited financial statements and reports; 99.9999% in favour.
  • Ordinary: Director rotation—Kailash Chand Sharma; 99.9999% in favour.
  • Ordinary: Ratification of cost auditor remuneration for 2026-27; 99.9999% in favour.
  • Special: WTD re-appointment for 3 years from 1 Oct 2026; 99.9999% in favour.

Directors & Appointments

  • Director changes: Kailash Chand Sharma re-appointed by rotation; Sharad Kumar Jain re-appointed WTD.

Auditors & Fees

  • Cost Auditor remuneration ratified for 2026-27.
Filed 20:33View Source
AGM/EGMAGM

Natraj Proteins conducts 35th AGM via VC/OAVM with four resolutions on agenda and pending results

AGM Details

  • Held 29 September 2026 at 2:00 PM through VC/OAVM; concluded 2:20 PM IST.
  • Cut-off date for participation: 22 September 2026; quorum met via VC/OAVM.
  • Deemed venue for compliance: Registered Office, Itarsi, MP.

Resolutions

  • Ordinary: Adopt Audited Financial Statements for year ended 31 March 2026.
  • Ordinary: Re-appoint Kailash Chand Sharma as director retiring by rotation.
  • Ordinary: Ratify remuneration payable to Cost Auditor for 2026-27.
  • Special: Re-appoint Sharad Kumar Jain as Whole-time Director from 1 October 2026.

Voting status

  • Results of remote/e-voting and AGM voting to be announced within two working days.
  • Scrutinizer report to be provided within two days; results to be uploaded on websites.
Filed 15:11View Source
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Natraj Proteins Limited – Closure of Trading Window from 1 October 2026 till completion of 48 hours after the declaration of Un-audited Financial Results for the quarter and half-year ended 30 September 2026

Natraj Proteins Limited – Closure of Trading Window from 1 October 2026 till completion of 48 hours after the declaration of Un-audited Financial Results for the quarter and half-year ended 30 September 2026

Filed 16:31View Source
9 Sept 20261 filing
Company UpdateGeneral

Natraj Proteins sets 35th AGM date and online AR access via VC/OAVM

AGM/AR communications

  • AGM for FY2025-26 scheduled 29 September 2026 at 2:00 PM via VC/OAVM.
  • AR and AGM notice to be sent electronically to members with registered emails.
  • Shareholders without registered emails will access AR/Notice online and may request physical copies.
  • Documents accessible on BSE website and CDS/evoting portal.
  • Letters dispatched under Reg 36(1)(b) of SEBI LODR to comply with disclosure requirements.
Filed 16:11View Source
8 Sept 20261 filing
Company UpdateNewspaper Publication

Submission of newspaper clipping of 35th Annual General Meeting of the company to be held on Tuesday 29th September, 2026

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 19:58View Source
7 Sept 20261 filing
OthersReg. 34 (1) Annual Report

Natraj Proteins FY2025-26: Revenue declines, PAT positive; high current borrowings; no dividend; governance updates

Financial performance

  • Revenue from operations: Rs 10,112.13 Lakhs for FY26, down from FY25.
  • Total income: Rs 10,138.96 Lakhs, down from Rs 11,827.13 Lakhs.
  • Profit before tax: Rs 110.58 Lakhs, reversal from prior year's loss.
  • Net profit after tax: Rs 113.51 Lakhs, turning positive.
  • Earnings per share: Rs 3.03 (basic and diluted).

Revenue mix & operations

  • Manufactured revenue: Rs 9,190.25 Lakhs; trading: Rs 748.85 Lakhs; Rice milling: Rs 173.03.
  • Total revenue from operations: Rs 10,112.13 Lakhs.
  • Single reportable segment; no segment disclosure required.
  • Other operating income: Rs 0.00 Lakhs.

Capital structure & liquidity

  • Current borrowings: Rs 3,602.65 Lakhs; non-current borrowings: Rs 6.02 Lakhs.
  • Equity share capital: Rs 374.70 Lakhs; no equity issues during year.
  • Debt-equity ratio: 1.08; current ratio: 1.47.
  • Cash and cash equivalents: Rs 22.34 Lakhs.
  • Deposits: None outstanding.

Cash flows & liquidity trend

  • Cash flow from operations: Rs -1,364.31 Lakhs.
  • Net cash from financing: Rs 1,101.14 Lakhs.
  • Net increase in cash: Rs 16.34 Lakhs; closing balance Rs 22.34 Lakhs.
  • No long-term cash outlays beyond ordinary course identified.

Governance & audit

  • Auditors: Bhutoria Ganesan & Co; Secretarial Auditor: D.K. Jain & Co.
  • CSR Committee dissolved; CSR not required for FY25-26.
  • Independent directors: Mishra, Kumar, Koserwal; four board committees.
  • Board meetings total four in FY26; separate ID meetings held.
  • Internal financial controls considered adequate; no material weaknesses.

Developments, risk & outlook

  • Solar power plant: 400 kWh rooftop installation; cost Rs 1.86 Crores.
  • Industry outlook: branded edible oil market to grow; DOC demand subdued.
  • Poultry use of DDGS affects DOC demand; higher price potential for de-oiled cakes.
  • Risk management: soy price volatility and supply risks; IFC framework in place.
  • Investor relations: Saksham Niveshak 100 Days Campaign launched.

Related party transactions & governance

  • Related party transactions are arm's length and board-approved.
  • Key management remuneration includes MD Rs 15.00 L, WTD Rs 6.60 L, CFO Rs 4.15 L.
Filed 15:09View Source
5 Sept 20261 filing
Company UpdateNewspaper Publication

Submission of copy of newspaper clippings of notice of 35th Annual General Meeting (AGM), Remote E- Voting, Book closure and other details.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 19:22View Source
14 Aug 20261 filing
Company UpdateNewspaper Publication

Submission of newspaper advertisement publication related to extract of quarterly Un-audited financial results of the company for the quarter ended 30th June, 2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 17:13View Source
Showing 10 of 34 filings